What is CBT's health score?

CABOT CORP (CBT) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CBT's estimated fair value?

Based on our 5-year discounted cash flow model, CABOT CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CBT undervalued or overvalued?

Our model currently rates CBT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

CABOT CORP (CBT)

Materials Undervalued low mixed

$90.39

Updated: 2026-07-18

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

65 Healthy

Risk Management

80 Strong

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Industry Related Stocks

Alcoa Corp (AA) AMERICAN BATTERY TECHNOLOGY Co (ABAT) ASCENT INDUSTRIES CO. (ACNT) American Clean Resources Group, Inc. (ACRG) ADURO CLEAN TECHNOLOGIES INC. (ADUR) ALBEMARLE CORP (ALB)

See all Materials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.